VTE Evidence Update from NICE (10/Feb/2012) A summary of selected new evidence relevant to NICE clinical guideline 92 ‘Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital’ (2010) was release on 8th February 2012
New ACCP Guidelines released (08/Feb/2012) The Antithrombotic Therapy and Prevention of Thrombosis: ACCP Evidence-Based Clinical Practice Guidelines, 9th Edition, have just been released.
Incidence rates of VTE after joint-replacement surgery (18/Jan/2012) A new review of studies that examined patients who underwent joint-replacement surgery and were taking the recommended anticoagulant prophylaxis estimates that one in 100 patients who undergo knee replacement and one in 200 who undergo hip replacement will suffer a symptomatic venous thromboembolic (VTE) event (1).
Costly blood clots common in cancer (02/Nov/2011) As many as 1 in 5 people risk developing a VTE within a year after undergoing treatment for some types of cancers, researchers reported at the 2011 European Multidisciplinary Cancer Congress, held in Stockholm, Sweden, September 23-27, 2011.
